What does synovial hypertrophy grade 1 (SH 1) and power Doppler (PD) indicate during musculoskeletal ultrasound (MSK USG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What SH 1 and PD Mean During MSK Ultrasound

SH 1 indicates mild synovial hypertrophy (grade 1 thickening of the joint synovium), while PD refers to power Doppler signal indicating active inflammation and increased blood flow within the synovium.

Understanding the Terms

Synovial Hypertrophy (SH)

According to EULAR standardized terminology, synovial hypertrophy is defined as hypoechoic thickening of the synovium detected on grayscale (B-mode) ultrasound 1. This is typically graded on a semiquantitative scale from 0-3:

  • Grade 0: No synovial thickening
  • Grade 1: Mild synovial thickening (SH 1)
  • Grade 2: Moderate synovial thickening
  • Grade 3: Severe synovial thickening

SH 1 represents the mildest detectable degree of synovial thickening above normal limits.

Power Doppler (PD)

Power Doppler signal represents increased blood flow (synovial hyperemia) within the thickened synovium 1. Histopathologic studies confirm that PD signals correlate with active inflammation, showing significantly more lymphocyte infiltration, vessel proliferation, and lining hyperplasia compared to PD-negative synovium 2.

PD is also graded 0-3 based on the amount of vascular signal detected within the synovial tissue.

Clinical Significance

Prognostic Implications

The presence of both SH and PD carries important prognostic information:

  • PD activity is strongly predictive of disease progression. In rheumatoid arthritis patients in clinical remission, PD synovitis increases the odds of radiographic progression by 12-fold (OR 12.21, p<0.001) 3
  • SH alone (even without PD) is also predictive, with a 2.3-fold increased odds of radiographic progression (OR 2.31, p=0.032) 3
  • Patients with PD activity have higher relapse rates: 47.1% versus 20.0% in those without PD signal (p=0.009) 3

Important Clinical Considerations

Subclinical inflammation is common: Even grade 1 synovial hypertrophy without Doppler activity can represent active disease that responds to treatment 4. Studies show that joints with SH but no PD signal still improve significantly during disease-modifying therapy, indicating these findings should not be dismissed as inactive disease.

Age and gender affect normal ranges: In asymptomatic individuals, mild synovial thickening can be present, particularly in elderly patients and varies by gender 5, 6. However, any PD signal is uncommon in healthy controls (present in only 0-1.2%) 6, making PD activity a more specific marker of pathologic inflammation.

Practical Application

When you see SH 1 with PD activity on a report:

  • This indicates mild synovial thickening with active inflammation
  • Consider this a sign of active disease requiring treatment optimization, even if the patient appears clinically well
  • This combination predicts future joint damage and disease flares
  • Follow-up imaging can assess treatment response

When you see SH 1 without PD:

  • Still represents abnormal findings that may indicate subclinical disease activity
  • Less predictive of progression than when PD is present, but not benign
  • Consider clinical context, as this can be sensitive to treatment changes 4

The combination of grayscale synovial hypertrophy grading and power Doppler assessment provides complementary information about both structural changes and active inflammation in the joint 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.